Innovita Biological Technology Co., Ltd. (SHA:688253)

China flag China · Delayed Price · Currency is CNY
35.35
-0.04 (-0.11%)
At close: Jan 22, 2026
7.64%
Market Cap4.80B
Revenue (ttm)430.96M
Net Income (ttm)133.44M
Shares Out134.87M
EPS (ttm)0.97
PE Ratio36.50
Forward PE32.33
Dividend0.56 (1.58%)
Ex-Dividend Daten/a
Volume1,091,647
Average Volume2,733,018
Open35.51
Previous Close35.39
Day's Range35.11 - 36.19
52-Week Range27.56 - 40.00
Beta0.94
RSI61.67
Earnings DateApr 28, 2026

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in the research and development, production and sales of POCT rapid diagnostic products. It offers covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test, tropical disease test, and hepatitis test. The company was founded in 2006 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 547
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688253
Full Company Profile

Financial Performance

In 2024, SHA:688253's revenue was 621.39 million, an increase of 29.99% compared to the previous year's 478.02 million. Earnings were 246.86 million, an increase of 41.92%.

Financial Statements